Literature DB >> 3127106

The use of macrophages stimulated by immune interferon as indicator cells in the mononuclear phagocyte assay.

E Wiener1, S F Garner.   

Abstract

Macrophages obtained from human monocytes by monolayer culture were stimulated with recombinant immune interferon. They were compared with unstimulated macrophages and monocytes as indicator cells in the mononuclear phagocyte assay, using both IgG anti-Rh(D)-coated complement-coated red cells. The presence of the interferon in the culture medium improved the adherence of macrophages in monolayers. The interferon markedly augmented the number of IgG-coated red cells which became attached to the macrophages and reduced the amount of antibody needed for red cell-macrophage interaction. This stimulatory effect occurred regardless of the IgG subclass composition of the anti-Rh(D) antibody. The activity of the stimulated macrophages to interact with IgG- or complement-coated red cells was considerably greater than that of monocytes. The results imply that macrophages treated with recombinant immune interferon are more sensitive than monocytes as indicator cells in the mononuclear phagocyte assay.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3127106     DOI: 10.1111/j.1365-2257.1987.tb00578.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  2 in total

1.  Bispecific anti-human red blood Rhesus-D antigen x anti Fc gamma RI targeted antibody-dependent cell-mediated cytotoxicity and phagocytosis by mononuclear leucocytes.

Authors:  E X Deramoudt; C Gilard; N Lepine; J M Alonso; J L Romet-Lemonne
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.

Authors:  E Wiener; V M Jolliffe; H C Scott; B M Kumpel; K M Thompson; M D Melamed; N C Hughes-Jones
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.